MedPath

Exploring radiosensitivity predictive factors using body fluid metabolomes for non-small cell lung cancer

Not Applicable
Conditions
non-small cell lung cancer
Registration Number
JPRN-UMIN000039209
Lead Sponsor
Department of Radiology, Tokyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
29
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with active interstitial pneumonia 2)Patients with severe liver cirrhosis, diabetes mellitus or cardiovascular diseases 3) Patients with malignancies other than lung cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We collected patients' saliva metabolites before, 2 weeks after, and 3 months after the start of radiotherapy, and just after the end of treatment. To search for independent patient-related risk factors for predicting future radiation pneumonitis using saliva metabolomes.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath